Article Text

Download PDFPDF
Sheep and goats
Treatment of cerebrospinal nematodiasis in a Boer Buck
  1. Ryan Breuer1,
  2. Paul Merkatoris2,
  3. Samantha Tepley3,
  4. Caitlyn Dierks3,
  5. Cassandra Klostermann3,
  6. Heather Flaherty3 and
  7. Joseph Smith2
  1. 1 Veterinary Clinical Sciences, Iowa State University College of Veterinary Medicine, Ames, Iowa, USA
  2. 2 VDPAM, Iowa State University College of Veterinary Medicine, Ames, Iowa, USA
  3. 3 Iowa State University College of Veterinary Medicine, Ames, Iowa, USA
  1. Correspondence to Dr Joseph Smith; jss303{at}iastate.edu

Abstract

A nine-month-old Boer Buck presented for an acute onset of pelvic limb ataxia. Radiographs, complete blood count and serum biochemistry were within normal limits. A cerebrospinal fluid analysis yielded an eosinophilic pleocytosis, consistent with cerebrospinal nematodiasis. Treatment with ivermectin, non-steroidal anti-inflammatories, fenbendazole and range of motion exercises resulted in partial recovery of pelvic limb function within five days. Within five months post treatment the buck’s ambulation had returned to a normal gait.

  • goat
  • cerebrospinal nematodiasis
  • pharmacology
View Full Text

Statistics from Altmetric.com

Footnotes

  • Contributors RB and PM were residents on the case and contributed to case management and manuscript construction. JS was the faculty clinician on the case and contributed to case management and manuscript construction. ST and CD were fourth-year veterinary students on the case and contributed to case management and manuscript construction. KC was a hospital intern and contributed to case research and manuscript construction. HF was the clinical pathologist on the case that aided in CSF preparation and interpretation as well as manuscript construction.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • Data sharing statement No additional data are available.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.